The United States has lost the measles elimination status it held for more than two decades, marking a significant reversal for public health in the country. The decision by the Pan American Health Organization, the regional office of the World Health Organization for the Americas, means health authorities no longer consider domestic transmission of measles to have been interrupted. The United States had achieved elimination in 2000, after more than 12 months without continuous local spread.
The change follows a wave of outbreaks that began in January 2025 and continued into 2026. Data from the Centers for Disease Control and Prevention list nearly 2,300 measles cases nationwide in 2025 and 5,412 confirmed cases so far in 2026. Those figures are considered likely undercounts, a common limitation when infections are missed or testing is delayed. Imported cases had occurred in previous years, but elimination status depends on preventing those introductions from becoming sustained chains of transmission.
Measles is among the most contagious human viruses, which makes community protection highly dependent on high immunity levels. Public health benchmarks generally place the threshold at about 95% immunity, achieved through vaccination or past infection, to prevent large outbreaks. U.S. vaccination coverage among school-age children has weakened in recent years, and only 10 states reported kindergarten measles, mumps and rubella vaccination rates above that threshold for the 2025-2026 school year, based on national school vaccination data tracked by the CDC.
The consequences extend beyond case counts. Measles can lead to pneumonia, brain inflammation, long-term disability and death, particularly among young children and people with weakened immune systems. State health counts have recorded eight measles-related deaths during the current resurgence, including cases in Pennsylvania, Wisconsin and New York, although not all have been reflected in federal totals. The disease can also damage immune memory, leaving survivors more vulnerable to other infections after recovery.
Regaining elimination status will require the United States to complete 12 consecutive months without continuous measles transmission. That target places renewed pressure on surveillance, rapid outbreak response and efforts to improve vaccine access and confidence. The loss of status does not mean measles is endemic permanently, but it signals that the margin protecting communities from sustained spread has narrowed sharply.
